16:09 EDT Aprea Therapeutics files to sell 4.39M shares of common stock for holders
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APRE:
- Aprea Therapeutics price target raised to $11 from $9 at Wedbush
- Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
- Aprea Therapeutics sees cash runway into 3Q25
- Aprea Therapeutics reports Q4 EPS (92c), consensus (77c)
- APRE Upcoming Earnings Report: What to Expect?